Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice

被引:46
作者
Adamcio, Bartosz [1 ,2 ]
Sperling, Swetlana [1 ]
Hagemeyer, Nora [1 ]
Walkinshaw, Gail [3 ]
Ehrenreich, Hannelore [1 ,2 ]
机构
[1] Max Planck Inst Expt Med, Div Clin Neurosci, D-37075 Gottingen, Niedersachsen, Germany
[2] DFG Res Ctr Mol Physiol Brain CMPB, Gottingen, Germany
[3] FibroGen Inc, San Francisco, CA 94158 USA
关键词
Fear conditioning test; Erythropoietin; EPO; VEGF; FG-4497; RECOMBINANT-HUMAN-ERYTHROPOIETIN; NERVOUS-SYSTEM; BRAIN; INHIBITION; NEUROPROTECTION; EXPRESSION; RECEPTOR; TARGET; HIF-1;
D O I
10.1016/j.bbr.2009.11.010
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
We have previously shown that high-dose erythropoietin (EPO) treatment improves hippocampal plasticity and cognitive performance in rodents and in patients suffering from neuro psychiatric diseases. It was therefore of interest to explore whether upregulation of endogenous EPO in brain by hypoxia inducible factor (HIF) stabilization would increase hippocampal memory similar to exogenous EPO. HIFs are transcription factors involved in the cellular response to low oxygen, including upregulation of transcripts like vascular endothelial growth factor (VEGF) and EPO. Under normal oxygen, prolylhydroxylases decrease HIF-alpha stability. This is banned by prolylhydroxylase inhibitors, which prevent oxygen dependent degradation and thus prolong HIF-alpha half life. In an experimental set-up identical to the one yielding Strong cognitive effects with EPO, healthy male 28-day-old mice received FG-4497, a HIF prolylhydroxylase inhibitor, or placebo intraperitoneally every other day for 3 weeks. Behavioral testing and hematocrit determinations were conducted in independent cohorts at 1, 3, or 4 weeks after treatment completion. Increased EPO and VEGF mRNA expression in hippocampus or primary hippocampal neurons 6 h after the application of FG-4497 confirmed its ability to stabilize HIF and upregulate HIF dependent transcription in brain. At 3 and 4 weeks after the last injection, respectively, FG-4497 treated mice compared to placebo mice had improved hippocampal memory in fear conditioning without change in hematocrit. In contrast, no improvement in memory was detected at I week, when the hematocrit was increased, indicating that cognitive improvement and hematocrit are not directly related. FG-4497 application for 3 weeks leads to delayed but lasting enhancement of hippocampal memory, making HIF stabilization an attractive target for pharmacological manipulation of cognition. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:80 / 84
页数:5
相关论文
共 21 条
[1]   Erythropoietin enhances hippocampal long-term potentiation and memory [J].
Adamcio, Bartosz ;
Sargin, Derya ;
Stradomska, Alicja ;
Medrihan, Lucian ;
Gertler, Christoph ;
Theis, Fabian ;
Zhang, Mingyue ;
Mueller, Michael ;
Hassouna, Imam ;
Hannke, Kathrin ;
Sperling, Swetlana ;
Radyushkin, Konstantin ;
El-Kordi, Ahmed ;
Schulze, Lizzy ;
Ronnenberg, Anja ;
Wolf, Fred ;
Brose, Nils ;
Rhee, Jeong-Seop ;
Zhang, Weiqi ;
Ehrenreich, Hannelore .
BMC BIOLOGY, 2008, 6 (1)
[2]   Emerging biological roles for erythropoietin in the nervous system [J].
Brines, M ;
Cerami, A .
NATURE REVIEWS NEUROSCIENCE, 2005, 6 (06) :484-494
[3]   VEGF links hippocampal activity with neurogenesis, learning and memory [J].
Cao, L ;
Jiao, XY ;
Zuzga, DS ;
Liu, YH ;
Fong, DM ;
Young, D ;
During, MJ .
NATURE GENETICS, 2004, 36 (08) :827-835
[4]   Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin [J].
Ehrenreich, H. ;
Hinze-Selch, D. ;
Stawicki, S. ;
Aust, C. ;
Knolle-Veentjer, S. ;
Wilms, S. ;
Heinz, G. ;
Erdag, S. ;
Jahn, H. ;
Degner, D. ;
Ritzen, M. ;
Mohr, A. ;
Wagner, M. ;
Schneider, U. ;
Bohn, M. ;
Huber, M. ;
Czernik, A. ;
Pollmaecher, T. ;
Maier, W. ;
Siren, A. -L. ;
Klosterkoetter, J. ;
Falkai, P. ;
Ruether, E. ;
Aldenhoff, J. B. ;
Krampe, H. .
MOLECULAR PSYCHIATRY, 2007, 12 (02) :206-220
[5]   Erythropoietin:: a candidate compound for neuroprotection in schizophrenia [J].
Ehrenreich, H ;
Degner, D ;
Meller, J ;
Brines, M ;
Béhé, M ;
Hasselblatt, M ;
Woldt, H ;
Falkai, P ;
Knerlich, F ;
Jacob, S ;
von Ahsen, N ;
Maier, W ;
Brück, W ;
Rüther, E ;
Cerami, A ;
Becker, W ;
Sirén, AL .
MOLECULAR PSYCHIATRY, 2004, 9 (01) :42-54
[6]   Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis [J].
Ehrenreich, Hannelore ;
Fischer, Benjamin ;
Norra, Christine ;
Schellenberger, Felix ;
Stender, Nike ;
Stiefel, Michael ;
Siren, Anna-Leena ;
Paulus, Walter ;
Nave, Klaus-Armin ;
Gold, Ralf ;
Bartels, Claudia .
BRAIN, 2007, 130 :2577-2588
[7]   Erythropoietin improves operant conditioning and stability of cognitive performance in mice [J].
El-Kordi, Ahmed ;
Radyushkin, Konstantin ;
Ehrenreich, Hannelore .
BMC BIOLOGY, 2009, 7
[8]   HIF-prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques [J].
Hsieh, Matthew M. ;
Linde, N. Seth ;
Wynter, Aisha ;
Metzger, Mark ;
Wong, Carol ;
Langsetmo, Ingrid ;
Lin, Al ;
Smith, Reginald ;
Rodgers, Griffin R. ;
Donahue, Robert E. ;
Klaus, Stephen J. ;
Tisdale, John F. .
BLOOD, 2007, 110 (06) :2140-2147
[9]   Erythropoietin after a century of research: younger than ever [J].
Jelkmann, Wolfgang .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 (03) :183-205
[10]   Vascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium/calmodulin protein kinase II and mammalian target of rapamycin [J].
Kim, Byung Woo ;
Choi, Minee ;
Kim, Yong-Seok ;
Park, Hyungju ;
Lee, Hye-Ryeon ;
Yun, Chae-Ok ;
Kim, Eun Joo ;
Choi, June-Seek ;
Kim, Sunoh ;
Rhim, Hyewon ;
Kaang, Bong-Kiun ;
Son, Hyeon .
CELLULAR SIGNALLING, 2008, 20 (04) :714-725